This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Douglas A. Dulli, MD
Department of Neurology

Ross L. Levine, MD
Departments of Neurology and Radiology

Raymond W. Chun, MD
Departments of Neurology and Pediatrics

Patricia Dinndorf, MD
Department of Pediatrics University of Wisconsin Clinical Sciences Center Madison, WI 53792

Arch Neurol. 1987;44(7):689.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—We read with great interest the article by Feldmann and Posner¹ in which they describe 14 adults (26 to 51 years of age) with transient neurologic dysfunction, almost all of whom had received mantle irradiation as well as chemotherapy for Hodgkin's disease. Recently, the following case of a 10-year-old girl with Hodgkin's disease who suffered transient neurologic dysfunction following two courses of doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, and dacarbazine therapy came to our attention. Her presentation shows a striking resemblance to the cases they describe, both in type and in duration of neurologic symptoms.

Report of a Case.

—A 10-year-old girl was diagnosed two months prior to admission with stage IA nodular sclerosing Hodgkin's disease. One month before admission, she tolerated her first course of this combination chemotherapy without incident. An echocardiogram performed then showed no right-to-left shunts or valvular abnormality. A second course of this . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?